Cancer Incidence and Mortality among Hispanic Individuals, Kings County (Brooklyn), 2016-2020
Source: New York State Cancer Registry
| Site of Cancer | Incidence | Mortality | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Males and Females | Males | Females | Males and Females | Males | Females | |||||||||||||
| Average Annual Cases | Rate per 100,000 Population | 95% CI | Average Annual Cases | Rate per 100,000 Males | 95% CI | Average Annual Cases | Rate per 100,000 Females | 95% CI | Average Annual Deaths | Rate per 100,000 Population | 95% CI | Average Annual Deaths | Rate per 100,000 Males | 95% CI | Average Annual Deaths | Rate per 100,000 Females | 95% CI | |
| All Invasive Malignant Tumors | 1,562.8 | 346.6 | 338.9-354.5 | 736.6 | 386.3 | 373.5-399.5 | 826.2 | 326.5 | 316.5-336.7 | 461.0 | 108.5 | 104.0-113.1 | 230.0 | 133.3 | 125.4-141.5 | 231.0 | 92.5 | 87.2-98.0 |
| Oral cavity and pharynx | 35.6 | 7.8 | 6.7-9.0 | 23.2 | 12.0 | 9.8-14.5 | 12.4 | 4.8 | 3.7-6.2 | 10.2 | 2.3 | 1.7-3.0 | 7.4 | 3.9 | 2.7-5.4 | 2.8 | 1.2 | 0.6-1.9 |
| Esophagus | 15.0 | 3.3 | 2.6-4.2 | 11.8 | 6.2 | 4.6-8.0 | 3.2 | 1.3 | 0.7-2.1 | 10.2 | 2.3 | 1.7-3.1 | 8.0 | 4.4 | 3.1-6.0 | 2.2 | 0.9 | 0.4-1.6 |
| Stomach | 51.0 | 11.6 | 10.2-13.1 | 31.0 | 16.8 | 14.2-19.8 | 20.0 | 7.8 | 6.3-9.5 | 22.4 | 5.2 | 4.3-6.3 | 13.4 | 7.5 | 5.8-9.6 | 9.0 | 3.6 | 2.6-4.9 |
| Colorectal | 131.6 | 30.3 | 28.0-32.8 | 71.8 | 39.1 | 35.0-43.5 | 59.8 | 24.2 | 21.6-27.2 | 45.6 | 10.9 | 9.5-12.5 | 22.4 | 12.8 | 10.5-15.5 | 23.2 | 9.5 | 7.9-11.4 |
| Colon excluding rectum | 90.6 | 21.0 | 19.1-23.0 | 48.0 | 26.3 | 23.0-30.0 | 42.6 | 17.3 | 15.0-19.8 | 37.0 | 8.9 | 7.7-10.3 | 17.8 | 10.5 | 8.4-13.0 | 19.2 | 7.9 | 6.4-9.6 |
| Rectum & rectosigmoid | 41.0 | 9.4 | 8.1-10.7 | 23.8 | 12.8 | 10.5-15.4 | 17.2 | 7.0 | 5.6-8.6 | 8.6 | 2.0 | 1.4-2.7 | 4.6 | 2.3 | 1.4-3.5 | 4.0 | 1.7 | 1.0-2.6 |
| Liver / intrahepatic bile duct | 59.8 | 12.9 | 11.4-14.5 | 41.4 | 20.7 | 17.9-23.8 | 18.4 | 7.1 | 5.7-8.7 | 34.6 | 7.7 | 6.6-9.0 | 23.0 | 11.8 | 9.7-14.3 | 11.6 | 4.6 | 3.5-6.0 |
| Pancreas | 49.6 | 11.3 | 9.9-12.8 | 23.0 | 12.4 | 10.2-15.0 | 26.6 | 10.5 | 8.8-12.4 | 38.2 | 9.0 | 7.8-10.4 | 19.8 | 11.3 | 9.1-13.8 | 18.4 | 7.4 | 6.0-9.1 |
| Larynx | 12.8 | 2.7 | 2.1-3.5 | 8.6 | 4.3 | 3.0-5.8 | 4.2 | 1.6 | 1.0-2.4 | 4.8 | 1.1 | 0.7-1.6 | 4.6 | 2.6 | 1.6-3.9 | 0.2 | 0.1 | 0.0-0.4 |
| Lung and bronchus | 132.6 | 30.5 | 28.2-32.9 | 65.6 | 37.2 | 33.1-41.6 | 67.0 | 26.2 | 23.4-29.2 | 67.8 | 16.0 | 14.3-17.8 | 37.2 | 21.8 | 18.7-25.3 | 30.6 | 12.2 | 10.3-14.3 |
| Melanoma of the skin | 10.0 | 2.3 | 1.7-3.1 | 4.8 | 2.6 | 1.6-3.9 | 5.2 | 2.1 | 1.4-3.1 | 1.0 | 0.3 | 0.1-0.6 | 0.4 | 0.3 | 0.0-1.0 | 0.6 | 0.2 | 0.0-0.7 |
| Female breast | 228.6 | 90.0 | 84.8-95.5 | 34.6 | 13.7 | 11.7-15.9 | ||||||||||||
| Cervix uteri | 25.4 | 10.2 | 8.5-12.2 | 7.6 | 3.1 | 2.2-4.2 | ||||||||||||
| Corpus uterus and NOS | 67.0 | 26.1 | 23.3-29.1 | 14.6 | 5.7 | 4.5-7.2 | ||||||||||||
| Ovary | 22.4 | 8.9 | 7.3-10.7 | 12.2 | 4.6 | 3.5-6.0 | ||||||||||||
| Prostate | 189.0 | 97.1 | 90.8-103.7 | 26.2 | 17.5 | 14.6-20.9 | ||||||||||||
| Testis | 12.0 | 4.5 | 3.4-5.8 | 0.0 | 0.0 | 0.0-0.4 | ||||||||||||
| Urinary bladder (incl. in situ) | 44.8 | 10.6 | 9.2-12.1 | 29.6 | 18.4 | 15.5-21.8 | 15.2 | 5.9 | 4.6-7.4 | 10.2 | 2.5 | 1.9-3.3 | 6.2 | 4.2 | 2.8-6.0 | 4.0 | 1.6 | 1.0-2.5 |
| Kidney and renal pelvis | 51.4 | 11.2 | 9.9-12.7 | 30.8 | 15.6 | 13.2-18.4 | 20.6 | 8.0 | 6.5-9.8 | 7.0 | 1.7 | 1.2-2.3 | 4.0 | 2.4 | 1.4-3.7 | 3.0 | 1.2 | 0.7-2.0 |
| Brain and other central nervous system | 25.4 | 5.4 | 4.5-6.5 | 14.2 | 6.8 | 5.2-8.6 | 11.2 | 4.4 | 3.3-5.7 | 10.6 | 2.4 | 1.8-3.1 | 6.6 | 3.3 | 2.2-4.7 | 4.0 | 1.6 | 1.0-2.5 |
| Thyroid | 68.2 | 14.5 | 13.0-16.1 | 12.0 | 5.5 | 4.2-7.1 | 56.2 | 22.7 | 20.1-25.5 | 1.2 | 0.3 | 0.1-0.6 | 0.2 | 0.1 | 0.0-0.5 | 1.0 | 0.4 | 0.1-1.0 |
| Hodgkin lymphoma | 14.4 | 3.0 | 2.4-3.8 | 8.2 | 3.7 | 2.6-5.0 | 6.2 | 2.4 | 1.6-3.4 | 1.8 | 0.4 | 0.2-0.8 | 1.0 | 0.6 | 0.2-1.3 | 0.8 | 0.3 | 0.1-0.9 |
| Non-Hodgkin lymphomas | 74.4 | 16.5 | 14.9-18.3 | 39.8 | 20.2 | 17.4-23.3 | 34.6 | 13.8 | 11.8-16.1 | 15.0 | 3.6 | 2.8-4.5 | 8.6 | 4.8 | 3.4-6.5 | 6.4 | 2.6 | 1.8-3.6 |
| Myeloma | 33.4 | 7.6 | 6.5-8.9 | 16.2 | 9.0 | 7.1-11.3 | 17.2 | 6.8 | 5.5-8.5 | 10.0 | 2.5 | 1.8-3.3 | 4.4 | 2.8 | 1.7-4.2 | 5.6 | 2.3 | 1.5-3.3 |
| Leukemias | 51.2 | 11.2 | 9.9-12.7 | 29.8 | 14.9 | 12.5-17.6 | 21.4 | 8.5 | 6.9-10.2 | 15.4 | 3.6 | 2.8-4.5 | 8.2 | 4.6 | 3.2-6.2 | 7.2 | 2.9 | 2.0-4.1 |
Notes
- Incidence data are provisional, November 2022.
- Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
- Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.
- NYSCR mortality statistics might differ slightly from official mortality statistics due to the availability of additional demographic information.
